Humanigen Inc (HGEN)

19.01 +0.79  +4.34% NASDAQ Jun 21, 16:59 USD
View Full Chart
Price Chart
View All HGEN News

News

View All Events

Events

Date Type Description
08/13/2021 Earnings Results Q2 2021 Earnings Results
05/13/2021 Earnings Results Q1 2021 Earnings Results
03/10/2021 Earnings Results Q4 2020 Earnings Results
11/11/2020 Earnings Results Q3 2020 Earnings Results
09/14/2020 Splits 1 to 5 Split
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
  • URL: https://www.humanigen.com
  • Investor Relations URL: https://ir.humanigen.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Aug. 13, 2021
  • Last Earnings Release: May. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
XBI SPDR® S&P Biotech ETF 0.79%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.48%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.